Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Convergent blood-brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models.

Fluids and barriers of the CNS·2026
Same author

Psychometric performance and student perceptions of AI- versus student-generated multiple-choice questions: a single-center randomized controlled trial.

BMC medical education·2026
Same author

Circulating natural killer cells are phenotypically and functionally altered in age-related macular degeneration.

Cell reports. Medicine·2026
Same author

Evidence of blood-brain barrier disruption in pathologic stage IV chronic traumatic encephalopathy without dementia.

Clinical neuropathology·2026
Same author

Screening metatranscriptomes for ultrastable RNA secondary structures reveals hidden bacteriophages and novel capsid nanomaterials.

bioRxiv : the preprint server for biology·2026
Same author

Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes.

Science translational medicine·2026

Related Experiment Video

Updated: May 1, 2026

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures
11:22

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures

Published on: December 22, 2014

21.2K

Antioxidant therapy for retinal disease.

Anna-Sophia Kiang1, Marian M Humphries, Matthew Campbell

  • 1Ocular Genetics Unit, School of Genetics and Microbiology, Trinity College Dublin, Dublin 2, Ireland, skiang@tcd.ie.

Advances in Experimental Medicine and Biology
|March 26, 2014
PubMed
Summary

Antioxidant compounds show promise in slowing retinal degeneration by targeting oxidative stress, a common factor in various eye diseases like retinitis pigmentosa and glaucoma.

More Related Videos

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
10:00

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells

Published on: December 11, 2020

2.1K
Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

6.2K

Related Experiment Videos

Last Updated: May 1, 2026

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures
11:22

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures

Published on: December 22, 2014

21.2K
Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
10:00

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells

Published on: December 11, 2020

2.1K
Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

6.2K

Area of Science:

  • Ophthalmology and Molecular Medicine
  • Neuroscience and Oxidative Stress Research

Background:

  • Retinal diseases involve complex genetic and environmental factors, affecting millions globally.
  • Conditions like retinitis pigmentosa, diabetic retinopathy, age-related macular degeneration, and glaucoma have diverse etiologies.
  • Oxidative stress is an early molecular process implicated in the degeneration of retinal tissues across multiple disease types.

Purpose of the Study:

  • To review compounds with antioxidant activity for potential therapeutic applications in retinal diseases.
  • To explore the mechanisms by which antioxidants may slow retinal degeneration.
  • To identify therapeutic strategies targeting common molecular pathways in diverse retinal conditions.

Main Methods:

  • Literature review of scientific studies on antioxidant compounds and retinal degeneration.
  • Analysis of research investigating the effects of antioxidants on retinal tissue.
  • Examination of proposed modes of action for antioxidant therapies in ophthalmology.

Main Results:

  • Several compounds with demonstrated antioxidant activity can slow retinal tissue degeneration.
  • These compounds act through various mechanisms to counteract oxidative stress.
  • Targeting oxidative stress offers a promising therapeutic avenue for multiple retinal diseases.

Conclusions:

  • Antioxidant therapies represent a viable strategy for managing complex retinal diseases.
  • Further research into specific antioxidant compounds and their mechanisms is warranted.
  • A unified approach targeting oxidative stress could benefit patients with various forms of vision loss.